Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells.

Gong, Baocheng; Zhang, Jinhua; Hua, Zhongyan; Liu, Zhihui; Thiele, Carol J; Li, Zhijie

Gong, Baocheng; Zhang, Jinhua; Hua, Zhongyan; Liu, Zhihui; Thiele, Carol J; Li, Zhijie.

Afiliação

Gong B; Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Zhang J; Medical Research Center, Liaoning Key Laboratory of Research and Application of Animal Models for Environment and Metabolic Diseases, Shengjing Hospital of China Medical University, Shenyang, China.
Hua Z; Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Liu Z; Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Thiele CJ; Medical Research Center, Liaoning Key Laboratory of Research and Application of Animal Models for Environment and Metabolic Diseases, Shengjing Hospital of China Medical University, Shenyang, China.
Li Z; Cellular and Molecular Biology Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Front Oncol ; 12: 984514, 2022.

Article em En | MEDLINE | ID: mdl-35992874

RESUMO

[This corrects the article DOI: 10.3389/fonc.2021.686898.].

Palavras-chave

BIM; Bcl-xl; MK-2206; ataxin-3; cisplatin; etoposide; neuroblastoma; perifosine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google